Videlis Nduba1, Anna H Van't Hoog2, Ellen Mitchell3, Peter Onyango4, Kayla Laserson5, Martien Borgdorff6. 1. Kenya Medical Research Institute (KEMRI)/CGHR Research and Public Health Collaboration, TB Research Branch, PO Box 1578, Kisumu, Kenya; Academic Medical Centre of the University of Amsterdam, Netherlands; Kenya Medical Research Institute, Centre for Respiratory Diseases Research (CRDR), Nairobi, Kenya. Electronic address: vnduba@kemricdc.org. 2. Kenya Medical Research Institute (KEMRI)/CGHR Research and Public Health Collaboration, TB Research Branch, PO Box 1578, Kisumu, Kenya; Academic Medical Centre of the University of Amsterdam, Netherlands; Amsterdam Institute for Global Health and Development, University of Amsterdam, Netherlands. 3. Academic Medical Centre of the University of Amsterdam, Netherlands; KNCV Tuberculosis Foundation, Netherlands. 4. Kenya Medical Research Institute (KEMRI)/CGHR Research and Public Health Collaboration, TB Research Branch, PO Box 1578, Kisumu, Kenya. 5. Kenya Medical Research Institute (KEMRI)/CGHR Research and Public Health Collaboration, TB Research Branch, PO Box 1578, Kisumu, Kenya; Center for Global Health, CDC Atlanta, Atlanta, Georgia, USA. 6. Kenya Medical Research Institute (KEMRI)/CGHR Research and Public Health Collaboration, TB Research Branch, PO Box 1578, Kisumu, Kenya; Academic Medical Centre of the University of Amsterdam, Netherlands; Center for Global Health, CDC Atlanta, Atlanta, Georgia, USA.
Abstract
OBJECTIVE: The aim of this study was to determine the prevalence of tuberculosis (TB) in adolescents in western Kenya. METHODS: A cohort study of 5004 adolescents aged 12-18 years was conducted. Adolescents were screened for prevalent TB using clinical criteria, history of TB contact, and a Mantoux test. Cases of suspected TB were investigated through two sputum examinations (microscopy and liquid culture) and chest radiography. RESULTS: Out of 5004 adolescents enrolled, 1960 (39.2%) were identified with suspected TB, including 1544 with a positive Mantoux (prevalence 1544/4808, 32.1%), 515 with symptoms suggestive of TB (10.3%), and 144 (2.9%) with household TB contact. Sixteen culture-confirmed (definite) and 18 probable pulmonary TB (PTB) cases were identified, reflecting a prevalence estimate of 3.2/1000 (definite) and 6.8/1000 all PTB, respectively. Only one smear-positive case was detected. The case notification rate among 12-18-year-old adolescents for all TB was 101/100000, yielding a patient diagnostic rate of 0.13 (95% confidence interval 0.03-3.7) cases detected per person-year for all TB. CONCLUSION: The prevalence of PTB among adolescents is high, with the majority of cases not detected routinely. Innovative active case finding including the wider use of Xpert MTB/RIF is needed to detect smear-negative TB among adolescents.
OBJECTIVE: The aim of this study was to determine the prevalence of tuberculosis (TB) in adolescents in western Kenya. METHODS: A cohort study of 5004 adolescents aged 12-18 years was conducted. Adolescents were screened for prevalent TB using clinical criteria, history of TB contact, and a Mantoux test. Cases of suspected TB were investigated through two sputum examinations (microscopy and liquid culture) and chest radiography. RESULTS: Out of 5004 adolescents enrolled, 1960 (39.2%) were identified with suspected TB, including 1544 with a positive Mantoux (prevalence 1544/4808, 32.1%), 515 with symptoms suggestive of TB (10.3%), and 144 (2.9%) with household TB contact. Sixteen culture-confirmed (definite) and 18 probable pulmonary TB (PTB) cases were identified, reflecting a prevalence estimate of 3.2/1000 (definite) and 6.8/1000 all PTB, respectively. Only one smear-positive case was detected. The case notification rate among 12-18-year-old adolescents for all TB was 101/100000, yielding a patient diagnostic rate of 0.13 (95% confidence interval 0.03-3.7) cases detected per person-year for all TB. CONCLUSION: The prevalence of PTB among adolescents is high, with the majority of cases not detected routinely. Innovative active case finding including the wider use of Xpert MTB/RIF is needed to detect smear-negative TB among adolescents.
Authors: L A Enane; J Eby; T Arscott-Mills; S Argabright; C Caiphus; B Kgwaadira; A P Steenhoff; E D Lowenthal Journal: Int J Tuberc Lung Dis Date: 2020-02-01 Impact factor: 2.373
Authors: Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi Journal: Cochrane Database Syst Rev Date: 2022-09-06
Authors: Kathryn J Snow; Lisa J Nelson; Charalambos Sismanidis; Susan M Sawyer; Stephen M Graham Journal: Epidemiol Infect Date: 2018-04-15 Impact factor: 4.434
Authors: Erick Wekesa Bunyasi; Humphrey Mulenga; Angelique K K Luabeya; Justin Shenje; Simon C Mendelsohn; Elisa Nemes; Michele Tameris; Robin Wood; Thomas J Scriba; Mark Hatherill Journal: PLoS One Date: 2020-07-01 Impact factor: 3.240
Authors: Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas Journal: Cochrane Database Syst Rev Date: 2020-08-27
Authors: Katherine C Horton; Peter MacPherson; Rein M G J Houben; Richard G White; Elizabeth L Corbett Journal: PLoS Med Date: 2016-09-06 Impact factor: 11.069